An angel investor based in San Francisco, California, United States, Ken Haas has 7 known investments: Vaxcyte, Scorpion Therapeutics, CRISPR Therapeutics, Clovis Oncology, Dicerna Pharmaceuticals, Personalis and Zogenix.
Is Ken Haas a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Series B
- Sector
- Healthcare
Contacts
Ken Haas portfolio companies (7)
- Vaxcyte
- Scorpion Therapeutics
- CRISPR Therapeutics
- Clovis Oncology
- Dicerna Pharmaceuticals
- Personalis
- Zogenix
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Clinical Trials, Life Science and Pharmaceuticals. Startups operating in these areas may find Ken Haas relevant.
Stage-wise, the known deals cluster around Series B rounds.
The portfolio and focus above give founders context on whether Ken Haas matches their raise.
Similar investors
Showing 19 of 98
Frequently asked questions
Who is Ken Haas?
Ken Haas is an angel investor based in San Francisco, California, United States with 7 known investments on file, among them Vaxcyte, Scorpion Therapeutics and CRISPR Therapeutics. The sections above list the sectors and stages attached to that record.
What does Ken Haas invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Clinical Trials, Life Science and Pharmaceuticals. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Ken Haas invest at?
The known deals of Ken Haas include Series B rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
How do I contact Ken Haas?
A phone number and a LinkedIn page are on file for Ken Haas. They are readable inside RaiseHunt after you create an account. The database holds no email address for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
